V81444 ( DrugBank: - )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	2

6. パーキンソン病

---

臨床試験数 : 2,307 /  薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02764892 (ClinicalTrials.gov)	August 2012	25/9/2015	A Study in Healthy Male Volunteers to Investigate a New Drug for the Treatment of Parkinson's Disease	An Open Label Study of V81444 Using Positron Emission Tomography to Assess Occupancy of Brain Adenosine A2A Receptors & Functional & Perfusion MRI to Explore Effects on Regional Brain Activity & Perfusion in Healthy Male Volunteers	Parkinson's Disease	Drug: V81444	Vernalis (R&D) Ltd	NULL	Completed	25 Years	55 Years	Male	6	Phase 1	NULL
2	NCT01634568 (ClinicalTrials.gov)	August 2011	20/6/2012	A Clinical Trial to Find Out V81444's Side Effects and Blood Levels in Healthy Men	A Double-blind, Randomised, Placebo-controlled Study of the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Oral Doses of V81444 in Healthy Male Volunteers	Parkinson's Disease	Drug: V81444	Vernalis (R&D) Ltd	NULL	Completed	18 Years	45 Years	Male	49	Phase 1	United Kingdom